US4113882A
(en)
|
1974-10-21 |
1978-09-12 |
Yamanouchi Pharmaceutical Co., Ltd. |
Stabilized oral prostaglandin formulation and the process for the preparation thereof
|
IT1202370B
(it)
|
1976-07-12 |
1989-02-09 |
Hoffmann La Roche |
Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
|
US4117121A
(en)
|
1977-04-22 |
1978-09-26 |
Hoffmann-La Roche Inc. |
Method of increasing bile flow and decreasing lipid levels
|
IT8167097A0
(it)
|
1981-01-26 |
1981-01-26 |
Unilever Nv |
Composizione cosmetica per il trattamento della pelle o dei capelli
|
US5288498A
(en)
|
1985-05-01 |
1994-02-22 |
University Of Utah Research Foundation |
Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
|
GB8417895D0
(en)
|
1984-07-13 |
1984-08-15 |
Marples B A |
Pharmaceutical anti-fungal composition
|
JPS61158995A
(ja)
|
1984-12-28 |
1986-07-18 |
Takara Shironaga |
脂肪肝,胆石,胃粘膜障害発生の予防薬または治療薬
|
US4722888A
(en)
|
1985-03-29 |
1988-02-02 |
United States Of America As Represented By The Department Of Health And Human Services |
Cell line producing human monoclonal antibody which binds to HTLV-I producing cells
|
US4866044A
(en)
|
1985-07-09 |
1989-09-12 |
Takeda Chemical Industries, Ltd. |
Solubilized composition of poorly-soluble pharmaceutical product
|
IT1213453B
(it)
|
1985-08-02 |
1989-12-20 |
Merz & Co Gmbh & Co |
Composizione farmaceutica.
|
US5326562A
(en)
|
1986-06-03 |
1994-07-05 |
Incyte Pharmaceuticals, Inc. |
Pharmaceutical dosage unit for treating inflammation comprising protease nexin-I
|
US4952411A
(en)
|
1987-02-25 |
1990-08-28 |
Trustees Of Columbia University In The City Of New York |
Method of inhibiting the transmission of AIDS virus
|
US5603932A
(en)
|
1987-04-14 |
1997-02-18 |
Boehringer Ingelheim International Gmbh |
Receptor of the minor human rhinovirus receptor group
|
US5690954A
(en)
|
1987-05-22 |
1997-11-25 |
Danbiosyst Uk Limited |
Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
|
EP0719860B1
(en)
|
1988-05-13 |
2009-12-16 |
Amgen Inc. |
Process for isolating and purifying G-CSF
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
IL89530A0
(en)
|
1989-03-08 |
1989-09-10 |
Jeffrey J Feigenbaum |
Compositions containing forskolin
|
GB8909022D0
(en)
|
1989-04-20 |
1989-06-07 |
Cortecs Ltd |
Pharmaceutical compositions
|
EP0408174A1
(en)
|
1989-07-12 |
1991-01-16 |
Warner-Lambert Company |
Antiseptic composition containing hexahydro-5-pyrimidinamine compounds
|
AU6461090A
(en)
|
1989-10-30 |
1991-05-02 |
Abbott Laboratories |
Injectable formulation for lipophilic drugs
|
US5085864A
(en)
|
1989-10-30 |
1992-02-04 |
Abbott Laboratories |
Injectable formulation for lipophilic drugs
|
CA2033725C
(en)
|
1990-01-24 |
2001-05-29 |
Folker Pittrof |
Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
|
US6120805A
(en)
|
1990-04-06 |
2000-09-19 |
Rhone-Poulenc Rorer Sa |
Microspheres, process for their preparation and their use
|
JP3032315B2
(ja)
|
1991-01-14 |
2000-04-17 |
健二 片桐 |
脂肪肝治療剤
|
EP0533492A3
(en)
|
1991-09-18 |
1994-08-10 |
Amgen Inc |
A hepatitis b vaccine formulation incorporating a bile acid salt
|
GB9212511D0
(en)
|
1992-06-12 |
1992-07-22 |
Cortecs Ltd |
Pharmaceutical compositions
|
US5344822A
(en)
|
1992-08-12 |
1994-09-06 |
The Rogosin Institute |
Methods useful in endotoxin prophylaxis and therapy
|
US5674855A
(en)
|
1992-08-12 |
1997-10-07 |
The Rogosin Institute |
Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
|
US6663885B1
(en)
|
1993-03-15 |
2003-12-16 |
A. Natterman & Cie Gmbh |
Aqueous liposome system and a method for the preparation of such a liposome system
|
GB9320597D0
(en)
|
1993-10-06 |
1993-11-24 |
Proteus Molecular Design |
Improvements in and realting to vaccines
|
US5395545A
(en)
|
1993-10-21 |
1995-03-07 |
Akzo N.V. |
Cleaning solution for automated analyzers
|
US5648343A
(en)
|
1994-02-28 |
1997-07-15 |
The University Of Georgia Research Foundation |
Method for treating LPS-mediated disorders
|
GB9417524D0
(en)
|
1994-08-31 |
1994-10-19 |
Cortecs Ltd |
Pharmaceutical compositions
|
US6932962B1
(en)
|
1994-12-22 |
2005-08-23 |
Astrazeneca Ab |
Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
|
JP2740153B2
(ja)
|
1995-03-07 |
1998-04-15 |
エフ・ホフマン−ラ ロシユ アーゲー |
混合ミセル
|
US5616342A
(en)
|
1995-04-11 |
1997-04-01 |
Pdt, Inc. |
Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
|
US5759445A
(en)
|
1995-05-24 |
1998-06-02 |
Matsushita Electric Industrial Co., Ltd. |
Lipid-dispersed solution and process for producing the same
|
US7002027B1
(en)
|
1996-01-08 |
2006-02-21 |
Canji, Inc. |
Compositions and methods for therapeutic use
|
US20040101569A1
(en)
|
1996-05-16 |
2004-05-27 |
Lorus Therapeutics Inc. |
Immunomodulating compositions from bile
|
US6255502B1
(en)
|
1996-07-11 |
2001-07-03 |
Farmarc Nederland B.V. |
Pharmaceutical composition containing acid addition salt of basic drug
|
US5952392A
(en)
|
1996-09-17 |
1999-09-14 |
Avanir Pharmaceuticals |
Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
|
FR2754709B1
(fr)
|
1996-10-23 |
1999-03-05 |
Sanofi Sa |
Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
|
KR100195348B1
(ko)
|
1996-10-31 |
1999-06-15 |
장용택 |
안정한 프로스타글란딘 e1-함유 주사제 조성물
|
US7351421B2
(en)
|
1996-11-05 |
2008-04-01 |
Hsing-Wen Sung |
Drug-eluting stent having collagen drug carrier chemically treated with genipin
|
US6417167B1
(en)
|
1997-02-05 |
2002-07-09 |
Kirin Beer Kabushiki Kaisha |
Lyophilized compositions containing shingoglycolipid and process for preparing them
|
EP0979647A4
(en)
|
1997-02-27 |
2006-07-19 |
Nippon Shinyaku Co Ltd |
FAT EMULSION FOR ORAL ADMINISTRATION
|
US5891083A
(en)
*
|
1997-04-22 |
1999-04-06 |
Capella; Rafael F. |
Suction lipolysis
|
US5914390A
(en)
|
1997-05-12 |
1999-06-22 |
Celtrix Pharmaceuticals, Inc. |
Methods for increasing yields of recombinant proteins
|
FR2763336B1
(fr)
|
1997-05-14 |
1999-08-06 |
Lvmh Rech |
Esters de tocopherol et leurs utilisations en cosmetique et pharmacie
|
US20020107291A1
(en)
|
1997-05-26 |
2002-08-08 |
Vincenzo De Tommaso |
Clear, injectable formulation of an anesthetic compound
|
US6197327B1
(en)
|
1997-06-11 |
2001-03-06 |
Umd, Inc. |
Device and method for treatment of dysmenorrhea
|
US6416779B1
(en)
|
1997-06-11 |
2002-07-09 |
Umd, Inc. |
Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
|
AU8067198A
(en)
|
1997-06-13 |
1998-12-30 |
University Of Nebraska Board Of Regents |
Compositions for delivery of biological agents and methods for the preparation thereof
|
GB2327945A
(en)
|
1997-07-31 |
1999-02-10 |
Medeva Europ Ltd |
Removal of endotoxin from vaccines
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
US6054421A
(en)
|
1997-09-23 |
2000-04-25 |
Scimed Life Systems, Inc. |
Medical emulsion lubricant
|
WO1999015179A1
(en)
|
1997-09-25 |
1999-04-01 |
Regents Of The University Of Minnesota |
Methods of limiting apoptosis of cells
|
NZ503800A
(en)
|
1997-10-09 |
2001-03-30 |
Beniamino Palmieri |
Bile acid salts of metals with physiological action and the use thereof in therapy
|
US6024961A
(en)
|
1997-11-14 |
2000-02-15 |
Washington University |
Recombinant avirulent immunogenic S typhi having rpos positive phenotype
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
US20050158408A1
(en)
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
US7303768B2
(en)
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
US6251428B1
(en)
|
1998-07-24 |
2001-06-26 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
DE19834814A1
(de)
|
1998-08-01 |
2000-02-03 |
Beiersdorf Ag |
Kosmetische und dermatologische Zubereitungen mit einem wirksamen Gehalt an Gallensäuren, ihren Salzen und/oder ihren Derivaten
|
TW570805B
(en)
|
1998-09-01 |
2004-01-11 |
Hoffmann La Roche |
Water-soluble pharmaceutical composition in an ionic complex
|
WO2000013029A1
(fr)
|
1998-09-01 |
2000-03-09 |
Eisai Co., Ltd |
Procede pour evaluer des injections contenant des analogues de lipide a
|
SE9803240D0
(sv)
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
US6417179B1
(en)
|
1998-10-13 |
2002-07-09 |
Craig G. Burkhart |
Ear wax solution
|
US6849263B2
(en)
|
1998-12-21 |
2005-02-01 |
Generex Pharmaceutical Incorporated |
Pharmaceutical compositions for buccal delivery of pain relief medications
|
US6451286B1
(en)
|
1998-12-21 |
2002-09-17 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
|
US6375975B1
(en)
|
1998-12-21 |
2002-04-23 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary application
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
CN100335122C
(zh)
|
1999-03-03 |
2007-09-05 |
伊莱利利公司 |
含有成胶束表面活性剂的棘白菌素药物制剂
|
US6350432B1
(en)
|
1999-03-19 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Pressurized container having an aerosolized pharmaceutical composition
|
US6375672B1
(en)
|
1999-03-22 |
2002-04-23 |
Board Of Trustees Of Michigan State University |
Method for controlling the chemical and heat induced responses of collagenous materials
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
US6489312B1
(en)
|
1999-06-15 |
2002-12-03 |
Medimmune Oncology, Inc. |
Pharmaceutical formulations comprising aminoalkyl phosphorothioates
|
US6225343B1
(en)
|
1999-06-16 |
2001-05-01 |
Nastech Pharmaceutical Company, Inc. |
Compositions and methods comprising morphine gluconate
|
US6573299B1
(en)
|
1999-09-20 |
2003-06-03 |
Advanced Medical Instruments |
Method and compositions for treatment of the aging eye
|
CN100558407C
(zh)
|
2000-02-04 |
2009-11-11 |
柳署弘 |
制备含有胆汁酸的澄清水溶液剂型
|
GB0009773D0
(en)
|
2000-04-19 |
2000-06-07 |
Univ Cardiff |
Particulate composition
|
FR2813189B1
(fr)
|
2000-08-31 |
2003-02-28 |
Oreal |
Creme cosmetique moussante pour le traitement des peaux grasses
|
EP1609468A3
(en)
|
2000-11-22 |
2006-01-25 |
Rxkinetix, Inc. |
A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
|
WO2002047694A1
(en)
|
2000-12-13 |
2002-06-20 |
Feher Janos |
Pharmaceutical compositions for treatment of digestive disorders and associated diseases
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US20030072807A1
(en)
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US6607784B2
(en)
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20040022862A1
(en)
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20030053956A1
(en)
|
2001-01-24 |
2003-03-20 |
Thomas Hofmann |
Alkylaryl polyether alcohol polymers for treatment and prophylaxis of snoring, sleep apnea, sudden infant death syndrome and for improvement of nasal breathing
|
SE0100901D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
New composition
|
CA2442539C
(en)
|
2001-03-27 |
2011-11-08 |
Phares Pharmaceutical Research N.V. |
Method and composition for solubilising a biologically active compound with low water solubility
|
WO2002089849A1
(en)
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
KR100994221B1
(ko)
|
2001-06-14 |
2010-11-12 |
오츠카 세이야쿠 가부시키가이샤 |
의약 조성물
|
US20030083286A1
(en)
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
US6713470B2
(en)
|
2002-01-22 |
2004-03-30 |
Ml Laboratories Plc |
Method of treatment
|
GB0207529D0
(en)
|
2002-04-02 |
2002-05-08 |
Norbrook Lab Ltd |
Injectable veterinary composition for small animals
|
CA2484637A1
(en)
|
2002-05-06 |
2003-11-20 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
CA2486909A1
(en)
|
2002-05-23 |
2003-12-04 |
Umd, Inc. |
Compositions and method for transmucosal drug delivery and cryoprotection
|
PL375874A1
(en)
|
2002-07-29 |
2005-12-12 |
Transform Pharmaceuticals, Inc. |
Aqueous 2,6-diisopropylphenol pharmaceutical compositions
|
US20040220283A1
(en)
|
2002-07-29 |
2004-11-04 |
Transform Pharmaceuticals, Inc. |
Aqueous 2,6-diisopropylphenol pharmaceutical compositions
|
US20050019404A1
(en)
|
2003-06-30 |
2005-01-27 |
Hsing-Wen Sung |
Drug-eluting biodegradable stent
|
US20050163821A1
(en)
|
2002-08-02 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting Biodegradable Stent and Delivery Means
|
KR100482269B1
(ko)
|
2002-10-08 |
2005-04-14 |
센츄론(주) |
2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
|
CN1708270A
(zh)
|
2002-10-29 |
2005-12-14 |
转化医药公司 |
丙泊酚与半胱氨酸
|
US20040118412A1
(en)
|
2002-12-24 |
2004-06-24 |
Piletti-Reyes Gianbattista Alberto |
Anatomical compression pad system
|
US20050079228A1
(en)
|
2003-05-30 |
2005-04-14 |
Ashish Jaiswal |
Clear, stable topical compositions of clarithromycin and processes for their preparation
|
KR20070029616A
(ko)
|
2003-08-22 |
2007-03-14 |
액티브 바이오틱스 인코포레이티드 |
리파마이신 유사체 및 그의 용도
|
US20050089555A1
(en)
|
2003-10-24 |
2005-04-28 |
Aventis Pharma Deutschland Gmbh |
Medicinal targeted local lipolysis
|
DE10361067A1
(de)
|
2003-12-22 |
2005-07-14 |
Aventis Pharma Deutschland Gmbh |
Medikamentöse Lipolyse von Fettansammlungen
|
US20050143347A1
(en)
|
2003-12-22 |
2005-06-30 |
Aventis Pharma Deutschland Gmbh |
Medicinal lipolysis of accumulations of fat
|
JP2007515494A
(ja)
|
2003-12-22 |
2007-06-14 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
注射可能なフォスファチジルコリン調製物
|
KR100638041B1
(ko)
|
2003-12-24 |
2006-10-23 |
주식회사 삼양사 |
수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
|
US20060127468A1
(en)
|
2004-05-19 |
2006-06-15 |
Kolodney Michael S |
Methods and related compositions for reduction of fat and skin tightening
|
US7754230B2
(en)
|
2004-05-19 |
2010-07-13 |
The Regents Of The University Of California |
Methods and related compositions for reduction of fat
|
SI1758590T1
(sl)
|
2004-05-19 |
2012-03-30 |
Los Angeles Biomed Res Inst |
Uporaba detergenta za nekirurško odstranitev maščobe
|
FR2870741B1
(fr)
|
2004-05-25 |
2008-03-14 |
Coletica Sa |
Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
|
WO2005117832A1
(en)
|
2004-06-03 |
2005-12-15 |
Bracco Research Sa |
Liposomal assembly for therapeutic and/or diagnostic use
|
US20050287199A1
(en)
|
2004-06-28 |
2005-12-29 |
Teresa Ann Denney |
Therapeutic micro nutrient composition for lipolysis and drug delivery
|
BRPI0418963A
(pt)
|
2004-07-20 |
2007-12-04 |
Libbs Farmaceutica Ltda |
composição para redução de gordura localizada, uso de compostos tensoativos farmceuticamente aceitáveis e métodos para redução de gordura localizada
|
US20060074057A1
(en)
|
2004-10-04 |
2006-04-06 |
Eric Marchewitz |
Use of chenodeoxycholic acid for reducing adipose tissue
|
US8436190B2
(en)
|
2005-01-14 |
2013-05-07 |
Cephalon, Inc. |
Bendamustine pharmaceutical compositions
|
US20060222695A1
(en)
|
2005-04-01 |
2006-10-05 |
Filiberto Zadini |
Deoxycholic acid liposome-based dermatological topical preparation
|
AU2006255097B2
(en)
|
2005-06-06 |
2012-02-09 |
Georgetown University |
Compositions and methods for lipo modeling
|
AU2007240652A1
(en)
|
2006-04-21 |
2007-11-01 |
Genaera Corporation |
Induction of weight loss and the selective inhibition of PTP1B
|
US20080318870A1
(en)
|
2007-06-19 |
2008-12-25 |
Kythera Biopharmaceuticals, Inc. |
Synthetic bile acid compositions and methods
|
US8242294B2
(en)
|
2007-06-19 |
2012-08-14 |
Kythera Biopharmaceuticals, Inc. |
Synthetic bile acid compositions and methods
|
JOP20180077A1
(ar)
|
2007-06-19 |
2019-01-30 |
Kythera Biopharmaceuticals Inc |
تركيبات وطرق لحمض صفراوي تخليقي
|
EP2278997B1
(en)
|
2008-04-21 |
2016-08-10 |
Nanobio Corporation |
Nanoemulsion influenza vaccine
|
CA2722445A1
(en)
|
2008-04-25 |
2009-10-29 |
Nanobio Corporation |
Nanoemulsions for treating fungal, yeast and mold infections
|
US8101593B2
(en)
|
2009-03-03 |
2012-01-24 |
Kythera Biopharmaceuticals, Inc. |
Formulations of deoxycholic acid and salts thereof
|
JP5420946B2
(ja)
|
2009-03-23 |
2014-02-19 |
富士フイルム株式会社 |
胆汁酸を含むミノキシジル水性組成物
|
GB2480632A
(en)
|
2010-05-25 |
2011-11-30 |
Kythera Biopharmaceuticals Inc |
Preparation of 12-keto and 12-alpha-hydroxy steroids
|
HUE054836T2
(hu)
|
2010-01-28 |
2021-10-28 |
Eagle Pharmaceuticals Inc |
Bendamusztin kiszerelései
|
AU2010359050B2
(en)
|
2010-08-12 |
2016-03-17 |
Kythera Biopharmaceuticals, Inc. |
Synthetic bile acid compositions and methods
|
CA2827643C
(en)
|
2011-02-18 |
2019-05-07 |
Kythera Biopharmaceuticals, Inc. |
Treatment of submental fat
|
US8653058B2
(en)
|
2011-04-05 |
2014-02-18 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
|
PL2561876T3
(pl)
|
2011-08-23 |
2014-09-30 |
Kythera Biopharmaceuticals Inc |
Formulacje kwasu deoksycholowego i ich sole
|
US8926407B2
(en)
|
2011-11-01 |
2015-01-06 |
Illinois Tool Works Inc. |
Devices and methods for removing a coating on a surface of a submerged pipeline
|
CN108366975A
(zh)
|
2015-11-04 |
2018-08-03 |
凯瑟拉生物制药有限公司 |
使用脱氧胆酸和其盐对堆积的脂肪的治疗
|